![]() |
About Us Pipeline R&D |
News & Investors Careers Contact |
|||||||||||||
![]() Overview Collaborations & Licensing Leadership Our Values Corporate Governance |
Ted Llana, Ph.D.Senior Vice President, Commercial and Corporate Development Ted Llana, Ph.D. has joined Facet Biotech, Senior Vice President, Commercial and Corporate Development, of the company. From September 2001 to November 2008, Dr. Llana held various positions of increasing responsibility at Biogen Idec Inc., including most recently as Vice President, Oncology/Rheumatology Strategic Business Unit. In his most recent role at Biogen Idec, he defined and executed the strategy to grow and progress Biogen Idec’s oncology and rheumatology pipelines and managed Biogen Idec’s Rituxan® collaboration with Genentech, Inc. Prior to working in the oncology business unit, Dr. Llana headed up corporate strategy at Biogen Idec and led global marketing at Biogen. Dr. Llana’s prior business experience includes serving as a partner at Documedics, Inc. and as a Vice President at Covance, Inc. where he provided strategic consulting on product commercialization and marketing in the pharmaceutical, biotechnology and medical device industries. Dr. Llana began his career as a Biologist at the National Cancer Institute. He received his Ph.D. in Cellular Immunology from Cornell University and his MBA from Georgetown. |
||||||||||||||